Skip to content
Clinical Trial Events
SCOPE Summit for Clinical Ops Executives

Talk Decentralized & Hybrid track

ROI: Return on Innovation – a Model for Avoiding Distraction in a World of BSOs (Bright Shiny Objects)

Tue, Feb 4, 2025 · 12:20–12:35 PM EST Rosen Shingle Creek

About this session

Innovation in digital and data has yielded great benefits over human history but the term "creative destruction" does not just connote the displacement of incumbent ways of working, but also the folly of adopting too early. In this presentation, I will suggest a third option—a focus on solving the most pressing problems of the pharmaceutical development business, using the least possible amount of its capacity for change.

Speaker

  • Alex Simmonds

    Global Drug Development Innovation Lead · Bristol Myers Squibb Co

    Speaker